Bullboard - Stock Discussion Forum BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > Tweeted NYT article from BIOV

View:

Post by 1DoxieDollar on Oct 13, 2022 3:32pm

Tweeted NYT article from BIOV

https://www.nytimes.com/2022/10/10/health/cancer-vaccines.html

New directions in cancer immunotherapy based on new research have boosted optimism for vaccines. With prior efficacy/safety data in >600 human subjects evaluating its technology platform, $BIOV $BVAXF at forefront of this renewed optimism for a cancer vax

152